Open access · CC-BY
via OpenAlex
A Novel Partial EMT-Associated Transcriptomic Signature for Prognostic Stratification in Ovarian Cancer
Chia‐Chia Chao, Cheng-Yao Lin, P. Y. Chen, Wen‐Tsung Huang, Teng-Song Weng, Sheng‐Yen Hsiao
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2026 · ▲ 1 citations
Abstract
Background: Partial epithelial-mesenchymal transition (p-EMT) is a dynamic cellular state associated with metastasis and adverse outcomes in multiple cancers, but its prognostic significance in ovarian cancer remains unclear. This study aimed to develop and validate an ovarian cancer-specific transcriptomic signature based on p-EMT-related genes, and to determine whether this signature can improve prognostic stratification and overall survival prediction across independent cohorts. Methods: A pan-cancer p-EMT gene set was curated from ten published studies. Using transcriptomic and clinical data from TCGA-OV (n = 488), a six-gene p-EMT signature was developed via LASSO regression to generate a patient-specific risk score. The score was integrated with clinical variables to construct a prognostic nomogram and validated in the external GEO cohort GSE140082 (n = 380) and GSE165808 (n = 51). Results: < 0.001). Incorporation with age and FIGO stage in a nomogram improved predictive performance, with AUCs of 0.727, 0.700, and 0.656 at 1-, 3-, and 5-year OS, respectively. External validation in GSE140082 and GSE165808 confirmed model robustness, yielding 3-year AUCs of 0.630 and 0.826, respectively, demonstrating preserved prognostic value across independent cohorts and disease stages. Conclusions: This six-gene p-EMT transcriptomic signature demonstrates prognostic value in ovarian cancer and offers potential for individualized risk stratification and clinical decisionsupport.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.32604/or.2026.074383
- Canonical
- link ↗
- Fetched
- 2026-11-16 MST
Cite this
APA
Chao, C., Lin, C., Chen, P.Y., Huang, W., Weng, T., & Hsiao, S. (2026). A Novel Partial EMT-Associated Transcriptomic Signature for Prognostic Stratification in Ovarian Cancer. <em>Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics</em>. https://doi.org/10.32604/or.2026.074383
Vancouver
Chao C, Lin C, Chen PY, Huang W, Weng T, Hsiao S. A Novel Partial EMT-Associated Transcriptomic Signature for Prognostic Stratification in Ovarian Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 2026. doi:10.32604/or.2026.074383.
BibTeX
@article{chiachia2026ANovel,
title = {A Novel Partial EMT-Associated Transcriptomic Signature for Prognostic Stratification in Ovarian Cancer},
author = {Chia‐Chia Chao and Cheng-Yao Lin and P. Y. Chen and Wen‐Tsung Huang and Teng-Song Weng and Sheng‐Yen Hsiao},
journal = {Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics},
year = {2026},
doi = {10.32604/or.2026.074383},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biology 2026
Open access · CC-BY
Age-Specific Transcriptomic Signatures for Classification of Progression-Free Survival Outcomes in Luminal A Breast Cancer: An Integrative Machine Learning Approach
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2026
Citation only
Identification of Ferro-Aging-Related Biomarkers for Ulcerative Colitis Through Integrated Machine Learning, Single-Cell Analysis, and Spatial Transcriptomics.
Journal of the American Geriatrics Society 2022
Open access · CC-BY
Frailty and affective disorders throughout adult life: A 5‐year follow‐up of the Lifelines Cohort Study
JCO Global Oncology 2026
Open access · CC-BY
A Clinically Adjusted Transcriptomic Signature for Survival Stratification in High-Grade Serous Ovarian Cancer
BMC Bioinformatics 2026
Open access · CC-BY
A knowledge graph-guided transcriptomic framework identifies a 20-gene prognostic signature for cervical cancer
Brain Communications 2021
Open access · CC-BY